People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.

As Thursday’s Supreme Court ruling on the health care law is examined, experts are citing concerns about the Medicaid decision, which could end up insuring fewer Americans as states opt out of expansion.

Educators across UCSF are considering the implications of the newly affirmed health care law on teaching future pharmacists, doctors, nurses and dentists.